We envision a future where every individual holds the key to their own genetic health, empowered by comprehensive insights derived from their entire genome. At Nucleus Genomics, we transform the vast complexities of DNA into actionable knowledge that can redefine healthcare and prevention.
By leveraging cutting-edge whole-genome sequencing and advanced polygenic risk scoring, our mission is to unlock the potential of genomic data to predict and prevent disease, making personalized health accessible to all, especially underserved communities. We are building a future where healthcare is proactive, informed, and tailored to the unique genetic makeup of each person.
Through collaborative innovation and relentless dedication, we are laying the foundation for a healthcare ecosystem grounded in genetics, equity, and early intervention, ushering in an era where genetic understanding shapes healthier lives globally.
Our Review
When we first heard about Nucleus Genomics, we'll admit we were skeptical. Another genetic testing company? But after diving into what they're actually doing, we found ourselves genuinely impressed by their approach to whole-genome sequencing.
Unlike the typical cheek-swab companies that look at a fraction of your DNA, Nucleus goes all-in. They're analyzing all 6 billion letters of your genome with over 99.9% accuracy, which is frankly remarkable for a consumer-facing service launched just three years ago.
What Makes Them Different
The real game-changer here is their polygenic risk scores (PRS). Instead of telling you about single gene mutations, they're crunching data from over a million common DNA variants to calculate your actual disease risks. It's like the difference between looking at one puzzle piece versus seeing the whole picture.
We're also fans of how they integrate environmental and lifestyle factors into their analysis. Your genes aren't your destiny, and Nucleus seems to understand that better than most players in this space.
The Smart Partnership Play
What caught our attention was their partnership with SteadyMD for genetic counseling. Too many companies dump complex genetic data on customers without proper support. Having actual genetic counselors available to help interpret results? That's the kind of thoughtful approach we love to see.
Their recent partnership with SumHealth to integrate into healthcare infrastructure also signals they're thinking beyond the direct-to-consumer model toward something more sustainable.
Who Should Consider This
This isn't for casual ancestry seekers or people just dipping their toes into genetic testing. Nucleus is best suited for health-conscious individuals who want comprehensive insights for preventive care planning.
Given their $31.6 million in funding and backing from serious investors like Founders Fund, they're clearly building something substantial. For anyone serious about understanding their genetic health risks, Nucleus represents the cutting edge of what's possible in consumer genomics right now.
Features
Whole-Genome Sequencing to analyze 6 billion genome letters with 99.9% accuracy
Polygenic Risk Scores (PRS) calculating combined impact of common DNA variants on diseases
Integration of environmental and lifestyle data for comprehensive risk assessment
Partnership with SteadyMD for genetic counseling
Focus on democratizing access to genetic insights and supporting preventive healthcare
FAQs
Ploy was founded in 2024.
Founded by Kian Sadeghi in 2021, Nucleus Genomics is a fertility startup that helps people have their best baby. It offers a complete end-to-end family planning platform, spanning advanced preconception testing, embryo analysis and full-service IVF care. With the goal of building generational health, Nucleus has raised over $32 million to date with investors including Founders Fund, Seven Seven Six, and Samsung Next.
Aleph Alpha
Fellow
Uare
Inkform
Centari
